Vividion Therapeutics
Benjamin Horning is an accomplished scientist with extensive experience in the field of organic chemistry and chemoproteomics. Since June 2016, Benjamin has held various positions at Vividion Therapeutics, Inc., rising from Scientist to Associate Director. Prior to this, Benjamin worked at The Scripps Research Institute as a Research Associate, focusing on novel chemoproteomic technologies to investigate enzyme functions in physiological and pathological contexts. Benjamin completed a Doctor of Philosophy in Organic Chemistry at Princeton University, where research was conducted under Professor David MacMillan on the total synthesis of Vincorine. Benjamin's academic background includes a Bachelor of Science in Biochemistry from the University of Oregon.
This person is not in any teams
Vividion Therapeutics
2 followers
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.